ANTX - AN2 Therapeutics, Inc.
IEX Last Trade
1.385
-0.005 -0.361%
Share volume: 1,459
Last Updated: Fri 27 Dec 2024 02:30:05 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.34%
PREVIOUS CLOSE
CHG
CHG%
$1.39
0.00
-0.36%
View ratios
| Fiscal Date | |
|---|---|
| Fiscal Quarter | |
| Report Date | |
| Total revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses | |
| Selling general and admin | |
| Research and development | |
| Total expenses | |
| Operating income | |
| Ebit | |
| Pretax income | |
| Income tax | |
| Net income basic | |
| Net income |